Design and evaluation of sulfadiazine derivatives as potent dual inhibitors of EGFR<sup>WT</sup> and EGFR<sup>T790M</sup>: integrating biological, molecular docking, and ADMET analysis
Hany M. Abd El‐Lateef, Hend A. A. Ezelarab, Ali M. Ali, Azhaar T. Alsaggaf, Wael A. Mahdi, Sultan Alshehri, Mohamed A. El Hamd, Moustafa O. Aboelez
Abstract
kinase inhibitory properties, positioning them as efficient candidates for further therapeutic development.
Topics & Concepts
SulfadiazineChemistryCombinatorial chemistryDocking (animal)Computational chemistryStereochemistryBiochemistryAntibioticsMedicineNursingLung Cancer Treatments and MutationsCancer therapeutics and mechanismsPI3K/AKT/mTOR signaling in cancer